Cyclopharm Ltd (CYC)

Currency in AUD
0.725
0.000(0.00%)
Delayed Data·
CYC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7250.780
52 wk Range
0.5601.475
Key Statistics
Bid/Ask
0.725 / 0.78
Prev. Close
0.725
Open
0.77
Day's Range
0.725-0.78
52 wk Range
0.56-1.475
Volume
-
Average Volume (3m)
131.49K
1-Year Change
-35.0877%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.001
Upside
+38.10%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Cyclopharm Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.001
(+38.10% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
25/02/2026
EPS / Forecast
-0.09 / --
Revenue / Forecast
16.9M / --
EPS Revisions
Last 90 days

CYC Income Statement

Compare CYC to Peers and Sector

Metrics to compare
CYC
Peers
Sector
Relationship
P/E Ratio
−5.3x−1.9x−0.5x
PEG Ratio
0.240.080.00
Price/Book
3.4x2.7x2.6x
Price / LTM Sales
2.8x2.2x3.2x
Upside (Analyst Target)
38.9%111.2%50.8%
Fair Value Upside
Unlock16.1%7.7%Unlock

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.24M1.85%1.65M
Other Institutional Investors
60.75M50.37%44.96M
Public Companies & Retail Investors
57.62M47.78%42.64M
Total
120.61M100.00%89.25M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Anglo Australian Christian And Charitable Fund10.95%13,211,3329,776
Regal Partners Limited9.95%12,002,7838,882

FAQ

What Is the Cyclopharm Ltd (CYC) Stock Price Today?

The Cyclopharm Ltd stock price today is 0.725 AUD.

What Stock Exchange Does Cyclopharm Ltd Trade On?

Cyclopharm Ltd is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Cyclopharm Ltd?

The stock symbol for Cyclopharm Ltd is "CYC."

What Is the Cyclopharm Ltd Market Cap?

As of today, Cyclopharm Ltd market cap is 91.400M AUD.

What Is Cyclopharm Ltd's Earnings Per Share (TTM)?

The Cyclopharm Ltd EPS (TTM) is -0.156.

From a Technical Analysis Perspective, Is CYC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cyclopharm Ltd Stock Split?

Cyclopharm Ltd has split 3 times.

How Many Employees Does Cyclopharm Ltd Have?

Cyclopharm Ltd has 109 employees.

What is the current trading status of Cyclopharm Ltd (CYC)?

As of 01/05/2026, Cyclopharm Ltd (CYC) is trading at a price of 0.725 AUD, with a previous close of 0.725 AUD. The stock has fluctuated within a day range of 0.725 AUD to 0.780 AUD, while its 52-week range spans from 0.560 AUD to 1.475 AUD.

What Is Cyclopharm Ltd (CYC) Price Target According to Analysts?

The average 12-month price target for Cyclopharm Ltd is 1.001 AUD, with a high estimate of 1.00125681 AUD and a low estimate of 1.00125681 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +38.10% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.